Mother loses UK legal fight to stop son's cancer radiotherapy

Key points
- A mother in Britain, who was so desperate to stop her cancer-stricken son having to undergo conventional medical treatment that she went into hiding with him, lost a court battle on Friday to prevent him receiving radiotherapy.
- Surgeons said Neon's operation on Wednesday had been successful but that radiotherapy was needed to ensure no residual tumor was left behind.
- The case of Sally Roberts, 37, a New Zealander living in Brighton, southern England, and the plight of her seven-year-old son has made headlines in Britain.
- Roberts wants to try alternative treatments first, including immunotherapy and photodynamic therapy for her son Neon.
A mother in Britain, who was so desperate to stop her cancer-stricken son having to undergo conventional medical treatment that she went into hiding with him, lost a court battle on Friday to prevent him receiving radiotherapy.
The case of Sally Roberts, 37, a New Zealander living in Brighton, southern England, and the plight of her seven-year-old son has made headlines in Britain.
Roberts wants to try alternative treatments first, including immunotherapy and photodynamic therapy for her son Neon. She has been told the boy needs treatment fast but fears the side-effects of conventional medicine.
Doctors treating the boy had warned that without radiotherapy he could die within three months
Judge David Bodey told the High Court in London the life-saving radiotherapy treatment could start against the mother's wishes, the Press Association reported.
"The mother has been through a terrible time. This sort of thing is every parent's nightmare," the judge said.
"But I am worried that her judgment has gone awry on the question of the seriousness of the threat which Neon faces."
The story of the sick blue-eyed blonde boy came to public attention earlier this month when Roberts prompted a nationwide police hunt by going into hiding with Neon for four days to stop him from undergoing the treatment.
The mother's relentless battle in court also cast a light on the dilemmas parents can face when dealing with the illness of a loved one, considering the short-term and long-term risks of a treatment and handling conflicting medical information available at the click of a mouse.
Roberts said in court she had researched on the Internet her son's condition - a fast-growing, high-grade brain tumor called medulloblastoma - and sought advice from specialists around the world because she did not trust British experts.
She feared radiotherapy would stunt the boy's growth, reduce his IQ, damage his thyroid and potentially leave him infertile.
Earlier this week, a judge ruled that Neon could undergo emergency surgery to remove a tumor which had resisted an initial operation in October, despite opposition from his mother, who found he appeared to be recovering after what she said was a "heartbreaking" stay in hospital.
"EXPERIMENTAL AND UNPROVEN"
Surgeons said Neon's operation on Wednesday had been successful but that radiotherapy was needed to ensure no residual tumor was left behind.
Neon's father Ben, who lives in London and is separated from Roberts, has sided with his son's doctors.
But his wife suggested exploring several alternative treatments, including immunotherapy, which mainly consists of stimulating the body's immune system to fight cancerous cells, and photodynamic therapy, which uses a photosensitizing agent and a source of light to kill malignant cells.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsBreast Cancer Specialist Presents Positive Results for Triple-Negative Breast Cancer Presurgery Chemotherapy Benefits
A breast cancer specialist and clinical researcher at Women & Infants Hospital of Rhode Island presented research yesterday at the 2014 San Antonio Breast Cancer Symposium showing that adding either the chemotherapy…
16 December 2014
NewsUseful markers to predict response to chemotherapy in patients with liver cancer
A study led by the researcher at the Institute of Biomedical Research (IDIBELL), Isabel Fabregat, could serve to select patients with hepatocellular carcinoma unresponsive to most frequently used drug in liver cancer:…
24 October 2014
NewsChemotherapy and stereotactic ablative radiation (SABR) consecutively may be promising treatment option for patients with advanced pancreatic cancer
For patients with locally advanced pancreatic cancer, the combination of chemotherapy and stereotactic ablative radiation (SABR) may be a promising treatment option, ultimately allowing them to undergo surgery that may…






